Clinical Trial Update: Anti-Hypertensive Agent (ACEi) and Heart Function Improvement in Association With Rho Kinase Activity Changes in Human [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update investigating an ACE inhibitor for improving heart function in association with changes in Rho kinase activity in heart failure.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• ACE inhibitor (angiotensin-converting enzyme inhibitor)

Snippet

Sponsor: National Cheng-Kung University Hospital | Conditions: Heart Failure | Phase 4 | Status: UNKNOWN